Global Thematic Partners’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-403,581
Closed -$8M 27
2020
Q1
$8M Sell
403,581
-14,570
-3% -$367K 0.64% 52
2019
Q4
$12.4M Buy
418,151
+77,709
+23% +$1.94M 0.76% 48
2019
Q3
$8.42M Sell
340,442
-64,797
-16% -$1.61M 0.58% 47
2019
Q2
$10M Sell
405,239
-68,826
-15% -$1.64M 0.54% 48
2019
Q1
$11.6M Buy
474,065
+34,308
+8% +$777K 0.54% 49
2018
Q4
$10M Sell
439,757
-41,811
-9% -$1.14M 0.54% 50
2018
Q3
$15.3M Sell
481,568
-25,349
-5% -$819K 0.6% 48
2018
Q2
$18.2M Buy
506,917
+32,968
+7% +$1.17M 0.67% 49
2018
Q1
$15.7M Sell
473,949
-140,103
-23% -$4.99M 0.54% 50
2017
Q4
$18.9M Buy
614,052
+49,011
+9% +$1.23M 0.62% 46
2017
Q3
$13.6M Buy
+565,041
New +$10.8M 0.43% 53

Other funds holding EDIT

Global Thematic Partners's EDIT Position: Q2 2020 in Review

Global Thematic Partners sold out of Editas Medicine (EDIT) in Q2 2020, closing a stake of 403,581 shares — an estimated $8M sold.

Global Thematic Partners first reported a position in EDIT in Q3 2017 and held it in 11 quarters. The position peaked at $18.9M in Q4 2017. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2020.

  • Global Thematic Partners reported no remaining Editas Medicine position as of Q2 2020 after selling out during the quarter.
  • Global Thematic Partners sold 403,581 Editas Medicine shares in Q2 2020, an estimated $8M.
  • Global Thematic Partners first reported a position in Editas Medicine in Q3 2017 and held it in 11 quarters.
  • Global Thematic Partners's Editas Medicine position peaked at $18.9M in Q4 2017.
  • 238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2020.

Based on Global Thematic Partners's 13F filing for Q2 2020, filed 31 Jul 2020.